Immunotherapy in older patients with cancer

por Granier, C., Gey, A., Roncelin, S., Weiss, L., Paillaud, E., Tartour, E.
Publicado 2021

Persistance à six mois des réponses immunitaires induites par une vaccination COVID-19 hétérologue ChAdOx1-nCoV19/BNT162b2 et homologue BNT162b2 – cohorte ANRS0001S COV-POPART...

por Lachâtre, M., Ninove, L., Tartour, E., Gilbert, C., Merrien, D., Cracowski, C., Verdon, R., Loubet, P., Launay, O., Wittkop, L.
Publicado 2023

Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients.

por Tartour, E., Dorval, T., Mosseri, V., Deneux, L., Mathiot, C., Brailly, H., Montero, F., Joyeux, I., Pouillart, P., Fridman, W. H.
Publicado 1994

Increased Performances of the Biological Diagnosis of the Antiphospholipid Syndrome by the Use of a Multiplex Assay

por Sénant, M., Rostane, H., Fernani-Oukil, F., Hosking, F., Bellery, F., Courchinoux, A., Tartour, E., Darnige, L., Dragon-Durey, M-A.
Publicado 2015

Persistence of anal squamous intraepithelial lesions and anal HPV infection in HIV-infected patientsdespite immune restoration under cART

por Piketty, C, Lanoy, E, Si-Mohamed, A, Cochand-Priolet, B, Trabelsi, S, Girard, P-M, Tubiana, R, Abramowitz, L, Tartour, E, Rouzioux, C, Weiss, L, Costagliola, D
Publicado 2010

CO8.1 - Challenges inhérents à la mise en place d'une cohorte vaccinale COVID-19 pour les populations particulières en temps de crise: la cohorte ANRS0001S COV-POPART

por Gilbert, C., Longobardi, J., Barquin, A., Kali, S., Mestre, S. Le, Circosta, S., Parfait, B., Pellegrin, I., Brassart, C., Gillet, S., Merchadou, L., Tartour, E., De Lamballerie, X., Loubet, P., Launay, O., Wittkop, L.
Publicado 2023

Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings

por Tartour, E, Mehtali, M, Sastre-Garau, X, Joyeux, I, Mathiot, C, Pleau, J M, Squiban, P, Rochlitz, C, Courtney, M, Jantscheff, P, Herrmann, R, Pouillart, P, Fridman, W H, Dorval, T
Publicado 2000

Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs)

por Daban, A, Gonnin, C, Phan, L, Saldmann, A, Granier, C, Lillo-Lelouet, A, Le Beller, C, Pouchot, J, Weiss, l, Tartour, E, Fabre, E, Medioni, J, Oudard, S, Vano, YA, Dragon-Durey, MA, Simonaggio, A.
Publicado 2023